Skip to main content

AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )

3.000 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Mar 1, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
July 26, 2007
Form 10QSB
Source: SEC/Edgar
May 14, 2007
Form 8-K
Source: SEC/Edgar
April 22, 2007
Form 10KSB
Source: SEC/Edgar
April 12, 2007
Form NT 10-K
Source: SEC/Edgar
April 02, 2007
Form 8-K
Source: SEC/Edgar
January 15, 2007
Form 8-K
Source: SEC/Edgar
January 02, 2007
Form 8-K
Source: SEC/Edgar
December 21, 2006
Form 10QSB
Source: SEC/Edgar
November 19, 2006
Form NT 10-Q
Source: SEC/Edgar
November 14, 2006
Form 8-K
Source: SEC/Edgar
October 12, 2006
Form 10QSB
Source: SEC/Edgar
August 20, 2006
Form NT 10-Q
Source: SEC/Edgar
August 13, 2006
Form 8-K
Source: SEC/Edgar
May 29, 2006
Form 10QSB
Source: SEC/Edgar
May 18, 2006
Form NT 10-Q
Source: SEC/Edgar
May 14, 2006
Form 8-K
Source: SEC/Edgar
May 04, 2006
Form 10KSB
Source: SEC/Edgar
March 30, 2006
Form 8-K/A
Source: SEC/Edgar
March 12, 2006
Form 8-K
Source: SEC/Edgar
February 13, 2006
Form 8-K
Source: SEC/Edgar
February 05, 2006
Form 8-K/A
Source: SEC/Edgar
January 26, 2006
Form 8-K
Source: SEC/Edgar
January 26, 2006
Form 8-K
Source: SEC/Edgar
January 25, 2006
Form 8-K
Source: SEC/Edgar
December 29, 2005
Form 8-K
Source: SEC/Edgar
November 30, 2005
Form 10QSB
Source: SEC/Edgar
November 13, 2005
Form 8-K
Source: SEC/Edgar
October 27, 2005
Form 8-K
Source: SEC/Edgar
September 06, 2005
Form DEF 14A
Source: SEC/Edgar
September 01, 2005
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.